Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Cancer Management and Research|September 28, 2020
Insulin Reduces the Efficacy of Vemurafenib and Trametinib in Melanoma CellsMarta Osrodek, Michal Rozanski, Malgorzata Czyz
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2019
Direct Measurement of Kinetic Parameters of ABCG2-Dependent Transport of Natural Flavonoids Using a Fluorogenic SubstrateMichal Rozanski, Maciej Studzian, Lukasz Pulaski
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 10, 2017
Vemurafenib and trametinib reduce expression of CTGF and IL-8 in V600EBRAF melanoma cellsMariusz L Hartman, Michal Rozanski, Marta Osrodek, et al.
Stroke|December 26, 2009
Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock?Martin Ebinger, Ivana Galinovic, Michal Rozanski, et al.
Nucleic Acids Research|August 28, 2016
S-Geranyl-2-thiouridine wobble nucleosides of bacterial tRNAs; chemical and enzymatic synthesis of S-geranylated-RNAs and their physicochemical characterizationMalgorzata Sierant, Grazyna Leszczynska, Klaudia Sadowska, et al.
Stroke|February 27, 2014
Elevated levels of hemoglobin A1c are associated with cerebral white matter disease in patients with strokeMichal Rozanski, Tobias B Richter, Ulrike Grittner, et al.
Neurology|August 2, 2015
Natural course of total mismatch and predictors for tissue infarctionBenjamin Hotter, Ann-Christin Ostwaldt, Anastasia Levichev-Connolly, et al.
European Radiology|April 23, 2015
Hyperintense acute reperfusion marker is associated with higher contrast agent dosage in acute ischaemic strokeAnn-Christin Ostwaldt, Michal Rozanski, Tabea Schaefer, et al.
Plos One|August 23, 2017
Exogenous growth factors bFGF, EGF and HGF do not influence viability and phenotype of V600EBRAF melanoma cells and their response to vemurafenib and trametinib in vitroIzabela Zalesna, Marta Osrodek, Mariusz L Hartman, et al.
Stroke|July 3, 2010
Clinical and radiological courses do not differ between fluid-attenuated inversion recovery-positive and negative patients with stroke after thrombolysisMartin Ebinger, Ann-Christin Ostwaldt, Ivana Galinovic, et al.
Pageof 4